Medication reference
Phenobarbital
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Phenobarbital (opens in a new tab)Original source URL: https://globalrph.com/dilution/phenobarbital/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/phenobarbital/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:47:07.985247+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- 68ee476cb910945d8d0123da931d511a410c75f5c6f5a50d9a1f9632f6a15a60
- Original response SHA-256
- 9a00f4da90e3b2d75e11174ab7eed7af731af9305c9b73a787c17a3ff116ded9
- Source body SHA-256
- a8509b61e42d631b7669c1db710ffa45303b134e3f214278619c9cd15d703274
Phenobarbital |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| NS |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| [0 to 100 mg] [50 ml] [30 min] [Over 100 mg] [100 ml] [30 min] Maximum rate: 100 mg/min. |
Stability / Miscellaneous |
| Dosing (adults): Alcohol withdrawal: 260 mg IV initially, followed by 130mg q30min to achieve light sedation. Sedation: Oral, I.M.: 30-120 mg/day in 2-3 divided doses Hypnotic: Oral, I.M., I.V., SubQ: 100-320 mg at bedtime Preoperative sedation: I.M.: 100-200 mg 1-1.5 hours before procedure Anticonvulsant: Anticonvulsant maintenance dose: Oral, I.V.: Therapeutic range: 15 - 40 mcg/ml. |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- phenobarbital
Source ID
H51-CB67C69B6420A4CB364CB215 - Generic name
- Phenobarbital
Source ID
H51-5B408F8C3DDB3661605689DC - Class
- Neurology and anticonvulsants
Source ID
H51-ACF0CE0E4BA8028B01491A65 - Subclass
- Barbiturate anticonvulsant
Source ID
H51-F79928464D19744EDB883CB7 - Primary uses
- Status epilepticus
Source ID
H51-5396A60A10A5C4C7D583B67C - Severe sedative withdrawal
Source ID
H51-9D0C53C3E2FF30AD5384B3E2 - Neonatal seizures
Source ID
H51-24D0C18CFAEE8FE0C84909FE
- Status epilepticus
- Mechanism
- Enhances GABA-A receptor inhibition mainly by prolonging chloride-channel opening.
Source ID
H51-E2E8F1FEAEA021BB8157B2CE - Mechanism level
- drug_specific
Source ID
H51-D53C56DE04503A5007C4A5DD - Basic dosing orientation
- Adult / Pediatric / Neonatal | Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | Patient- and indication-specific | See current package insert | IV push
Source ID
H51-C68A3BE2AF46AF4158E83D12 - Administration orientation
- Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute cap; 65 or 130 mg/mL; dilute per policy for controlled administration; Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute cap
Source ID
H51-0892CE2A13B40DA4FC26CF6A - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-1D4DF3ED1C69D1126B49DECC - Key safety orientation
- Apnea, hypotension, bradycardia, profound sedation, and tissue injury.
Source ID
H51-9FCB0D911539C1469CF34177
- Apnea, hypotension, bradycardia, profound sedation, and tissue injury.
- Coverage path
- structured_local_snapshot
Source ID
H51-52113C6F62AB338F5F2ECA0E - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-9C7FA3D669D22E1D11586EFC - Legacy title
- Phenobarbital
Source ID
H51-64AD425E8F2DB9D0B03EA720 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-D056CA56B75C60A7C816FD76 - Search text
- Phenobarbital Neurology and anticonvulsants Barbiturate anticonvulsant Status epilepticus Severe sedative withdrawal Neonatal seizures Enhances GABA-A receptor inhibition mainly by prolonging chloride-channel opening. Adult / Pediatric / Neonatal | Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | Patient- and indication-specific | See current package insert | IV push Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute cap; 65 or 130 mg/mL; dilute per policy for controlled administration; Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute cap Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Apnea, hypotension, bradycardia, profound sedation, and tissue injury. Structured GlobalRPh route snapshot
Source ID
H51-26A2AA11239D087A6D956D61 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Phenobarbital (opens in a new tab)
Source ID
H51-B5AC71D56DB816988E0709ED - Official access mode
- search
Source ID
H51-D6666C8109FDCC36B3BFB8EF - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Phenobarbital (opens in a new tab)
Source ID
H51-D20B0414193734B7A0434202 - Official search query
- Phenobarbital
Source ID
H51-B825E7BCDC0DF906B9C15588 - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-78E025352DAF7D13E0E6CF28
No separate structured rows were bundled for preparation, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status | Notes |
|---|---|---|---|---|---|
Source IDH51-95774831C9DA33D91F0044CBSource IDH51-48DE956858E29D6E3EAB32D6 | Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight basedSource IDH51-4B852AAFC39218B946DB0BD0 | 65 or 130 mg/mL; dilute per policy for controlled administrationSource IDH51-B02415334D7A7C7585121E3B | Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute capSource IDH51-0868DBA36420A5A32CA004DA | Use only when ordered and supported by current labeling or institutional policySource IDH51-32DE8D24AD58E89482AFEE11 | Use a secure IV line and monitor for precipitation/compatibility. Slower rates are required in unstable patients.Source IDH51-17599FBFAEE5E52E4F7DD80C |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-67CA61D55EF6A86979465430Source IDH51-85E4E58C3212C773C0ECF070 | Adult / Pediatric / NeonatalSource IDH51-CE290CBE5A41858E80CD3814 | Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight basedSource IDH51-A72497D8BC5FADCAA84DAE80 | Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight basedSource IDH51-B2B3E4896C1FCEAB33F24FBC | Patient- and indication-specificSource IDH51-01280B3B020E3B229794DF42 | See current package insertSource IDH51-97D41D54F1DB128690E0415F | Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute capSource IDH51-DE1CDCEE851FCE6D7A430B06 | Existing GlobalRPh IV push snapshotSource IDH51-4592E468BC155788B609B05F | Use only when ordered and supported by current labeling or institutional policy Use a secure IV line and monitor for precipitation/compatibility. Slower rates are required in unstable patients.Source IDH51-12DE0A442B99CE6A699A81EE |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-43B03A4083332F9885DF74E9 - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-29195D27140B7B858D982E61 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-B7E883720FFB0673976FAA11
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Status epilepticus
Source ID
H51-14258E3AC25217DABF1CA313 - Severe sedative withdrawal
Source ID
H51-BEA34101DEFFE3D90782CEAE - Neonatal seizures
Source ID
H51-6A027A53ABA01BC6CCDFCD7A
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Apnea, hypotension, bradycardia, profound sedation, and tissue injury.
Source ID
H51-0D7B56165DB509AB3A63B40C
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Continuous ECG, blood pressure, oxygenation, ventilation
Source ID
H51-80758B7FE3D382A4D14C95C0 - Serum concentration when indicated
Source ID
H51-8526D4ADFAB519876D29E35F
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
phenobarbitalSource ID
H51-14699F24CD93B901215EBECAGeneric name
PhenobarbitalSource ID
H51-12F7B35F63DED23B137F151DClass
Neurology and anticonvulsantsSource ID
H51-0F9314C8581F29E47E12E105Subclass
Barbiturate anticonvulsantSource ID
H51-DB35F03D3F3C39314E365D92Summary
Barbiturate loading requires controlled rate, continuous cardiopulmonary monitoring, and immediate airway support availability.Source ID
H51-0A51188B01A86A69668C60C9Populations
- Adult
Source ID
H51-19F59097958AB15450021376 - Pediatric
Source ID
H51-793C66A588FE1DDBC7413F4E - Neonatal
Source ID
H51-F7BDC3AAD290F373CFBFD83B
Evidence tier
IV push safety normalization - verify stocked productSource ID
H51-DF3E649D97C577597DBFAF1AHigh alert
trueSource ID
H51-4D4C79D1E065FAC28DA08F6BHazardous
falseSource ID
H51-9C009CB957E9C105FE746B67Status
ActiveSource ID
H51-05EDF4B177795B043060AC2BReviewed
2026-08-29Source ID
H51-183FC1EFA0F7C67E11AAE167Version added
1.2Source ID
H51-5F60CEE16B669F25F41E93A8Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-3161AE140AD2AF335DF79969Source IDH51-AADF3B0EE235289037D127C9 | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Phenobarbital (opens in a new tab)Source IDH51-6399188AFBCF054E6C764C65 | PrimarySource IDH51-BDE8D500C4671AD7917AF17E |
Source IDH51-403901096DC138A2E14010E4Source IDH51-A907D0ADC1926CE11C5DAD12 | legacy:autoSource IDH51-4E63130072E5A1C153E6972C | LegacySource IDH51-F010C54508D834CA8B8C529E |
Legacy title
PhenobarbitalSource ID
H51-6F83507E533242E255D069F5Clinical release verification
- Audit version
- 3.4
Source ID
H51-B6275DF53002A5B99548621B - Audited on
- 2026-08-30
Source ID
H51-6BEA407ADE2D31F2BFAF0A09 - Level
- amber
Source ID
H51-47A728A9C36775FA6CCC7C91 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-2ACBE0AA7BB161621E46D762 - Exact current label candidate
- false
Source ID
H51-6FCD5FC4F669527A052CE13C - Numeric support ratio
- 0
Source ID
H51-D90CE07477D0B8DCD921669C - Reference url count
- 1
Source ID
H51-B82E5AF9534310C1474F7A9C - Broken reference count
- 0
Source ID
H51-D007236A2D04D44D2B9D57BD - Point of use confirmation required
- true
Source ID
H51-E17F62149271A5C28CC64661 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-945D335E3279458740780407 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Phenobarbital (opens in a new tab)
Source ID
H51-CFFC720E9F1686B04416913E
Dosing source fields
Id
phenobarbitalSource ID
H51-D7093945467D85962A192165Generic name
PhenobarbitalSource ID
H51-F8ABEB21812C3D208ABCE9CECoverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-73727F87A2468A3C20F4CC72Package insert
- Query name
- Phenobarbital
Source ID
H51-0E17AEB01D437CB05A8C02A1 - Product and route must match
- true
Source ID
H51-B89F731643958256CBD1F1CA - Live current label enabled
- false
Source ID
H51-BA403A5C90EC7F501DD4FB3B - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-6EBF01A8B075D1FBBCEA2640 - Direct official label access enabled
- true
Source ID
H51-3BB0677EEB709A7761CD158F - Outbound server request required
- false
Source ID
H51-C9E14E695E46B1A39C744FDD - Local summary status
- not_bundled
Source ID
H51-BD5D52E652811A9FA3196BA7
Clinical review
- Locally normalized
- false
Source ID
H51-A020EF400B8A387586E56DCB - Reviewed
- 2026-08-29
Source ID
H51-4AC533ADB05C3703E5E4D265 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-D1F56EDD7E4ACA2784DF31C5
Clinical release verification
- Audit version
- 3.4
Source ID
H51-988CA96FB3BC6FD4C58E7513 - Audited on
- 2026-08-30
Source ID
H51-2ECBF611188DA516B796D3FD - Level
- amber
Source ID
H51-B45EF8402F5A0CFA09720F9A - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-0EA5424844C4207BE59A5731 - Exact current label candidate
- false
Source ID
H51-D4CEC6E4FE474BCB7859C0CF - Numeric support ratio
- 0
Source ID
H51-3F5019ADAA4B8AA01FF326A6 - Reference url count
- 1
Source ID
H51-B8D53F0F8D4DC24DB9CA909E - Broken reference count
- 0
Source ID
H51-0794FED5D4F7D3236A2620B6 - Point of use confirmation required
- true
Source ID
H51-D8540A47CE7882016A7865EA - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-C8817696D8EA69DEE27CD13C - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Phenobarbital (opens in a new tab)
Source ID
H51-5E4CBD788C030F0962CE80D5
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- phenobarbital
Source ID
H51-3DD560CC4176E399CD8C98C3 - Name
- Phenobarbital
Source ID
H51-5AB0C87809F84582B426F68F - Therapeutic class
- Neurology and anticonvulsants
Source ID
H51-40A2E8A5105A755FA3762165 - Review version
- 3.1
Source ID
H51-5AD3F51437C6CF2932F6C535 - Review date
- 2026-08-30
Source ID
H51-BFC563F24523230AD083C37B - Release status
- no_released_dilution_current_label_review_required
Source ID
H51-C2F2DFAEFB634A20C2C8A908 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-E786D33317BB17770A822033 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-1DB32FDB5A7D2430C6A3F558
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-CCCF4E132BC99F182981BD0C - Reconstitution concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-1CC44B141302B618A67F2556 - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-939016CA69B453BEFB206A07 - Appropriate standardized containers
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-411F86CAB9B609C225F8A7A9 - Adult dosing range
- Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based
Source ID
H51-359C867C2CB35CA11D4D8B57 - Pediatric dosing range
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source. | existing_route_snapshots: route: IV push | population: Adult / Pediatric / Neonatal | indication: Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | dose: Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | interval: Patient- and indication-specific | duration: See current package insert | administration: Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute cap | source_level: Existing GlobalRPh IV push snapshot | notes: Use only when ordered and supported by current labeling or institutional policy Use a secure IV line and monitor for precipitation/compatibility. Slower rates are required in unstable patients. | warnings: Apnea, hypotension, bradycardia, profound sedation, and tissue injury. | monitoring: Continuous ECG, blood pressure, oxygenation, ventilation | Serum concentration when indicated | populations: Adult | Pediatric | Neonatal | evidence_tier: IV push safety normalization - verify stocked product | high_alert: true | hazardous: false | status: Active | reviewed: 2026-08-29 | version_added: 1.2 | sources: label: DailyMed label search | url: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Phenobarbital | kind: Primary | label: GlobalRPh legacy IV dilution monograph | url: legacy:auto | kind: Legacy | legacy_title: Phenobarbital
Source ID
H51-2297062F3E3BA47CB6FA7913 - Neonatal dosing range
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source. | existing_route_snapshots: route: IV push | population: Adult / Pediatric / Neonatal | indication: Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | dose: Adult loading commonly 10 to 20 mg/kg; pediatric/neonatal weight based | interval: Patient- and indication-specific | duration: See current package insert | administration: Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute cap | source_level: Existing GlobalRPh IV push snapshot | notes: Use only when ordered and supported by current labeling or institutional policy Use a secure IV line and monitor for precipitation/compatibility. Slower rates are required in unstable patients. | warnings: Apnea, hypotension, bradycardia, profound sedation, and tissue injury. | monitoring: Continuous ECG, blood pressure, oxygenation, ventilation | Serum concentration when indicated | populations: Adult | Pediatric | Neonatal | evidence_tier: IV push safety normalization - verify stocked product | high_alert: true | hazardous: false | status: Active | reviewed: 2026-08-29 | version_added: 1.2 | sources: label: DailyMed label search | url: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Phenobarbital | kind: Primary | label: GlobalRPh legacy IV dilution monograph | url: legacy:auto | kind: Legacy | legacy_title: Phenobarbital
Source ID
H51-B77BE79B261B1C3A3BDB7ED2 - Infusion time
- Adult maximum 60 mg/min; pediatric commonly 1 to 2 mg/kg/min with lower absolute cap
Source ID
H51-70EEA5F229055B215995FF6C - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-F4AAB3E5E2E388E84886FAD0 - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-7A5BD4DF1BC70EF50F58E08C - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Phenobarbital (opens in a new tab)
Source ID
H51-D21F0B7B69CB51302AF9A723
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-6F43B696B5E1CD3EA504435C
- Reconstitution concentration
- Primary
- not_found
Source ID
H51-C709AA48755177B139D6E726
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-D2E4C991F7C28F64B477C228
- Appropriate standardized containers
- Primary
- not_found
Source ID
H51-764A550B30ABE5F8FCEC9827
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-D7EE65CBC8E639F1399EE445
- Pediatric dosing range
- Primary
- existing_record_text
Source ID
H51-118F55C7F7354C2E07C76DF2
- Neonatal dosing range
- Primary
- existing_record_text
Source ID
H51-55E027EECC42C82FA7732177
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-69659BA9298531F8BF174CAF
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-E0B6205D9EC1993099BC1A5C
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-B39B757C821C4A59FA9B4BAA
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-72951C0B5D5320C23637C279 - Guide generation allowed
- true
Source ID
H51-D4D3F1BF50484452F8427260
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-19C64DBDF15F8ED112242C31 - Guide generation allowed
- false
Source ID
H51-935D95FAAD95CA2493FCD60A
- Neonatal
- Applicability
- supported_or_source_present
Source ID
H51-ADF001A854BFA9F33BC812CB - Guide generation allowed
- false
Source ID
H51-08BD2770FBD69D8FD6211226
- Route presence
- Structured dilution
- false
Source ID
H51-52172503AED240D7AB486A19 - Iv push
- true
Source ID
H51-417BC17F2CBE554DA41B1FEA - Continuous infusion
- false
Source ID
H51-ECEEF6F4739F612A9C5993B4 - Pediatric source
- true
Source ID
H51-812CF83223FC0A191B997C2E - Neonatal source
- true
Source ID
H51-169C445EC0325E8DD05B558C
- Legacy reference
- Status
- not_available
Source ID
H51-5F7B29BC94F2C69CB4EA9DC6
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-78545FD5B529737AE510BC7D
- Source files
- catalog.json
Source ID
H51-4887DFF354A015592D34598C - dosing.json
Source ID
H51-6C983FC7DE178DF879F2C4F6 - legacy-map.json
Source ID
H51-580E0FF5C7DFF5AFA8A77F61 - new-in-v1.2.json
Source ID
H51-E4BCE1448A812010AC76DAA6
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-C2795F4717CE969B52568C7D
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-14699F24CD93B901215EBECA | catalog.json/records/195/id | Historical; current review incomplete |
H51-12F7B35F63DED23B137F151D | catalog.json/records/195/generic_name | Historical; current review incomplete |
H51-0F9314C8581F29E47E12E105 | catalog.json/records/195/class | Historical; current review incomplete |
H51-DB35F03D3F3C39314E365D92 | catalog.json/records/195/subclass | Historical; current review incomplete |
H51-0A51188B01A86A69668C60C9 | catalog.json/records/195/summary | Historical; current review incomplete |
H51-14258E3AC25217DABF1CA313 | catalog.json/records/195/common_uses/0 | Historical; current review incomplete |
H51-BEA34101DEFFE3D90782CEAE | catalog.json/records/195/common_uses/1 | Historical; current review incomplete |
H51-6A027A53ABA01BC6CCDFCD7A | catalog.json/records/195/common_uses/2 | Historical; current review incomplete |
H51-95774831C9DA33D91F0044CB | catalog.json/records/195/iv_push/0 | Historical; current review incomplete |
H51-48DE956858E29D6E3EAB32D6 | catalog.json/records/195/iv_push/0/population | Historical; current review incomplete |
H51-4B852AAFC39218B946DB0BD0 | catalog.json/records/195/iv_push/0/dose_scope | Historical; current review incomplete |
H51-B02415334D7A7C7585121E3B | catalog.json/records/195/iv_push/0/concentration | Historical; current review incomplete |
H51-0868DBA36420A5A32CA004DA | catalog.json/records/195/iv_push/0/rate | Historical; current review incomplete |
H51-32DE8D24AD58E89482AFEE11 | catalog.json/records/195/iv_push/0/status | Historical; current review incomplete |
H51-17599FBFAEE5E52E4F7DD80C | catalog.json/records/195/iv_push/0/notes | Historical; current review incomplete |
H51-0D7B56165DB509AB3A63B40C | catalog.json/records/195/warnings/0 | Historical; current review incomplete |
H51-80758B7FE3D382A4D14C95C0 | catalog.json/records/195/monitoring/0 | Historical; current review incomplete |
H51-8526D4ADFAB519876D29E35F | catalog.json/records/195/monitoring/1 | Historical; current review incomplete |
H51-19F59097958AB15450021376 | catalog.json/records/195/populations/0 | Historical; current review incomplete |
H51-793C66A588FE1DDBC7413F4E | catalog.json/records/195/populations/1 | Historical; current review incomplete |
H51-F7BDC3AAD290F373CFBFD83B | catalog.json/records/195/populations/2 | Historical; current review incomplete |
H51-DF3E649D97C577597DBFAF1A | catalog.json/records/195/evidence_tier | Historical; current review incomplete |
H51-4D4C79D1E065FAC28DA08F6B | catalog.json/records/195/high_alert | Historical; current review incomplete |
H51-9C009CB957E9C105FE746B67 | catalog.json/records/195/hazardous | Historical; current review incomplete |
H51-05EDF4B177795B043060AC2B | catalog.json/records/195/status | Historical; current review incomplete |
H51-183FC1EFA0F7C67E11AAE167 | catalog.json/records/195/reviewed | Historical; current review incomplete |
H51-5F60CEE16B669F25F41E93A8 | catalog.json/records/195/version_added | Historical; current review incomplete |
H51-3161AE140AD2AF335DF79969 | catalog.json/records/195/sources/0 | Historical; current review incomplete |
H51-AADF3B0EE235289037D127C9 | catalog.json/records/195/sources/0/label | Historical; current review incomplete |
H51-6399188AFBCF054E6C764C65 | catalog.json/records/195/sources/0/url | Historical; current review incomplete |
H51-BDE8D500C4671AD7917AF17E | catalog.json/records/195/sources/0/kind | Historical; current review incomplete |
H51-403901096DC138A2E14010E4 | catalog.json/records/195/sources/1 | Historical; current review incomplete |
H51-A907D0ADC1926CE11C5DAD12 | catalog.json/records/195/sources/1/label | Historical; current review incomplete |
H51-4E63130072E5A1C153E6972C | catalog.json/records/195/sources/1/url | Historical; current review incomplete |
H51-F010C54508D834CA8B8C529E | catalog.json/records/195/sources/1/kind | Historical; current review incomplete |
H51-6F83507E533242E255D069F5 | catalog.json/records/195/legacy_title | Historical; current review incomplete |
H51-B6275DF53002A5B99548621B | catalog.json/records/195/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-6BEA407ADE2D31F2BFAF0A09 | catalog.json/records/195/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-47A728A9C36775FA6CCC7C91 | catalog.json/records/195/clinical_release_verification/level | Historical; current review incomplete |
H51-2ACBE0AA7BB161621E46D762 | catalog.json/records/195/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-6FCD5FC4F669527A052CE13C | catalog.json/records/195/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-AA5D1F99796B03EFCD9F41A6 | catalog.json/records/195/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-A7C80986FDB9A6B64FC47306 | catalog.json/records/195/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-D90CE07477D0B8DCD921669C | catalog.json/records/195/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-B82E5AF9534310C1474F7A9C | catalog.json/records/195/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-D007236A2D04D44D2B9D57BD | catalog.json/records/195/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-E17F62149271A5C28CC64661 | catalog.json/records/195/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-945D335E3279458740780407 | catalog.json/records/195/clinical_release_verification/note | Historical; current review incomplete |
H51-CFFC720E9F1686B04416913E | catalog.json/records/195/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-D7093945467D85962A192165 | dosing.json/records/195/id | Historical; current review incomplete |
H51-F8ABEB21812C3D208ABCE9CE | dosing.json/records/195/generic_name | Historical; current review incomplete |
H51-73727F87A2468A3C20F4CC72 | dosing.json/records/195/coverage_status | Historical; current review incomplete |
H51-0E17AEB01D437CB05A8C02A1 | dosing.json/records/195/package_insert/query_name | Historical; current review incomplete |
H51-8CFE98C9A0C9147567ADB477 | dosing.json/records/195/package_insert/preferred_setid | Historical; current review incomplete |
H51-B89F731643958256CBD1F1CA | dosing.json/records/195/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-BA403A5C90EC7F501DD4FB3B | dosing.json/records/195/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-6EBF01A8B075D1FBBCEA2640 | dosing.json/records/195/package_insert/source_priority | Historical; current review incomplete |
H51-3BB0677EEB709A7761CD158F | dosing.json/records/195/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-C9E14E695E46B1A39C744FDD | dosing.json/records/195/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-BD5D52E652811A9FA3196BA7 | dosing.json/records/195/package_insert/local_summary_status | Historical; current review incomplete |
H51-43B03A4083332F9885DF74E9 | dosing.json/records/195/renal/classification | Historical; current review incomplete |
H51-29195D27140B7B858D982E61 | dosing.json/records/195/renal/summary | Historical; current review incomplete |
H51-B7E883720FFB0673976FAA11 | dosing.json/records/195/renal/method_note | Historical; current review incomplete |
H51-67CA61D55EF6A86979465430 | dosing.json/records/195/existing_route_snapshots/0 | Historical; current review incomplete |
H51-85E4E58C3212C773C0ECF070 | dosing.json/records/195/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-CE290CBE5A41858E80CD3814 | dosing.json/records/195/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-A72497D8BC5FADCAA84DAE80 | dosing.json/records/195/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-B2B3E4896C1FCEAB33F24FBC | dosing.json/records/195/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-01280B3B020E3B229794DF42 | dosing.json/records/195/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-97D41D54F1DB128690E0415F | dosing.json/records/195/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-DE1CDCEE851FCE6D7A430B06 | dosing.json/records/195/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-4592E468BC155788B609B05F | dosing.json/records/195/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-12DE0A442B99CE6A699A81EE | dosing.json/records/195/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-A020EF400B8A387586E56DCB | dosing.json/records/195/clinical_review/locally_normalized | Historical; current review incomplete |
H51-4AC533ADB05C3703E5E4D265 | dosing.json/records/195/clinical_review/reviewed | Historical; current review incomplete |
H51-D1F56EDD7E4ACA2784DF31C5 | dosing.json/records/195/clinical_review/status | Historical; current review incomplete |
H51-988CA96FB3BC6FD4C58E7513 | dosing.json/records/195/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-2ECBF611188DA516B796D3FD | dosing.json/records/195/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-B45EF8402F5A0CFA09720F9A | dosing.json/records/195/clinical_release_verification/level | Historical; current review incomplete |
H51-0EA5424844C4207BE59A5731 | dosing.json/records/195/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-D4CEC6E4FE474BCB7859C0CF | dosing.json/records/195/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-19CF5F8E117C41E5D4C8C1CE | dosing.json/records/195/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-6AA77E9752EEA9E27C681339 | dosing.json/records/195/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-3F5019ADAA4B8AA01FF326A6 | dosing.json/records/195/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-B8D53F0F8D4DC24DB9CA909E | dosing.json/records/195/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-0794FED5D4F7D3236A2620B6 | dosing.json/records/195/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-D8540A47CE7882016A7865EA | dosing.json/records/195/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-C8817696D8EA69DEE27CD13C | dosing.json/records/195/clinical_release_verification/note | Historical; current review incomplete |
H51-5E4CBD788C030F0962CE80D5 | dosing.json/records/195/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-CB67C69B6420A4CB364CB215 | first-look-v5.1.json/records/195/id | Historical; current review incomplete |
H51-5B408F8C3DDB3661605689DC | first-look-v5.1.json/records/195/generic_name | Historical; current review incomplete |
H51-ACF0CE0E4BA8028B01491A65 | first-look-v5.1.json/records/195/class | Historical; current review incomplete |
H51-F79928464D19744EDB883CB7 | first-look-v5.1.json/records/195/subclass | Historical; current review incomplete |
H51-5396A60A10A5C4C7D583B67C | first-look-v5.1.json/records/195/primary_uses/0 | Historical; current review incomplete |
H51-9D0C53C3E2FF30AD5384B3E2 | first-look-v5.1.json/records/195/primary_uses/1 | Historical; current review incomplete |
H51-24D0C18CFAEE8FE0C84909FE | first-look-v5.1.json/records/195/primary_uses/2 | Historical; current review incomplete |
H51-E2E8F1FEAEA021BB8157B2CE | first-look-v5.1.json/records/195/mechanism | Historical; current review incomplete |
H51-D53C56DE04503A5007C4A5DD | first-look-v5.1.json/records/195/mechanism_level | Historical; current review incomplete |
H51-C68A3BE2AF46AF4158E83D12 | first-look-v5.1.json/records/195/basic_dosing_orientation | Historical; current review incomplete |
H51-0892CE2A13B40DA4FC26CF6A | first-look-v5.1.json/records/195/administration_orientation | Historical; current review incomplete |
H51-1D4DF3ED1C69D1126B49DECC | first-look-v5.1.json/records/195/renal_and_population_orientation | Historical; current review incomplete |
H51-9FCB0D911539C1469CF34177 | first-look-v5.1.json/records/195/key_safety_orientation/0 | Historical; current review incomplete |
H51-52113C6F62AB338F5F2ECA0E | first-look-v5.1.json/records/195/coverage_path | Historical; current review incomplete |
H51-9C7FA3D669D22E1D11586EFC | first-look-v5.1.json/records/195/coverage_path_label | Historical; current review incomplete |
H51-B3D59E73B7F621180A8CAF7C | first-look-v5.1.json/records/195/official_label_url | Historical; current review incomplete |
H51-64AD425E8F2DB9D0B03EA720 | first-look-v5.1.json/records/195/legacy_title | Historical; current review incomplete |
H51-D056CA56B75C60A7C816FD76 | first-look-v5.1.json/records/195/review_note | Historical; current review incomplete |
H51-26A2AA11239D087A6D956D61 | first-look-v5.1.json/records/195/search_text | Historical; current review incomplete |
H51-B5AC71D56DB816988E0709ED | first-look-v5.1.json/records/195/official_search_url | Historical; current review incomplete |
H51-D6666C8109FDCC36B3BFB8EF | first-look-v5.1.json/records/195/official_access_mode | Historical; current review incomplete |
H51-D20B0414193734B7A0434202 | first-look-v5.1.json/records/195/official_access_url | Historical; current review incomplete |
H51-B825E7BCDC0DF906B9C15588 | first-look-v5.1.json/records/195/official_search_query | Historical; current review incomplete |
H51-78E025352DAF7D13E0E6CF28 | first-look-v5.1.json/records/195/official_access_reason | Historical; current review incomplete |
H51-3DD560CC4176E399CD8C98C3 | preparation-assessments-v3.8.json/195/id | Historical; current review incomplete |
H51-5AB0C87809F84582B426F68F | preparation-assessments-v3.8.json/195/name | Historical; current review incomplete |
H51-10D7D5645A535EB141C9800A | preparation-assessments-v3.8.json/195/brands | Historical; current review incomplete |
H51-40A2E8A5105A755FA3762165 | preparation-assessments-v3.8.json/195/therapeutic_class | Historical; current review incomplete |
H51-5AD3F51437C6CF2932F6C535 | preparation-assessments-v3.8.json/195/review_version | Historical; current review incomplete |
H51-BFC563F24523230AD083C37B | preparation-assessments-v3.8.json/195/review_date | Historical; current review incomplete |
H51-C2F2DFAEFB634A20C2C8A908 | preparation-assessments-v3.8.json/195/release_status | Historical; current review incomplete |
H51-E786D33317BB17770A822033 | preparation-assessments-v3.8.json/195/market_status/status | Historical; current review incomplete |
H51-1DB32FDB5A7D2430C6A3F558 | preparation-assessments-v3.8.json/195/market_status/basis | Historical; current review incomplete |
H51-CCCF4E132BC99F182981BD0C | preparation-assessments-v3.8.json/195/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-1CC44B141302B618A67F2556 | preparation-assessments-v3.8.json/195/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-939016CA69B453BEFB206A07 | preparation-assessments-v3.8.json/195/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-411F86CAB9B609C225F8A7A9 | preparation-assessments-v3.8.json/195/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-359C867C2CB35CA11D4D8B57 | preparation-assessments-v3.8.json/195/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-2297062F3E3BA47CB6FA7913 | preparation-assessments-v3.8.json/195/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-B77BE79B261B1C3A3BDB7ED2 | preparation-assessments-v3.8.json/195/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-70EEA5F229055B215995FF6C | preparation-assessments-v3.8.json/195/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-F4AAB3E5E2E388E84886FAD0 | preparation-assessments-v3.8.json/195/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-84EE8F4852B7A501E22DE5C6 | preparation-assessments-v3.8.json/195/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-6EB0478AA52CBF47E281056F | preparation-assessments-v3.8.json/195/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-58BA6440BD74691599415A8E | preparation-assessments-v3.8.json/195/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-1293D9AED9A40DC08FB1739A | preparation-assessments-v3.8.json/195/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-7A5BD4DF1BC70EF50F58E08C | preparation-assessments-v3.8.json/195/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-D21F0B7B69CB51302AF9A723 | preparation-assessments-v3.8.json/195/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-6F43B696B5E1CD3EA504435C | preparation-assessments-v3.8.json/195/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-C709AA48755177B139D6E726 | preparation-assessments-v3.8.json/195/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-D2E4C991F7C28F64B477C228 | preparation-assessments-v3.8.json/195/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-764A550B30ABE5F8FCEC9827 | preparation-assessments-v3.8.json/195/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-D7EE65CBC8E639F1399EE445 | preparation-assessments-v3.8.json/195/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-118F55C7F7354C2E07C76DF2 | preparation-assessments-v3.8.json/195/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-55E027EECC42C82FA7732177 | preparation-assessments-v3.8.json/195/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-69659BA9298531F8BF174CAF | preparation-assessments-v3.8.json/195/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-E0B6205D9EC1993099BC1A5C | preparation-assessments-v3.8.json/195/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-B39B757C821C4A59FA9B4BAA | preparation-assessments-v3.8.json/195/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-72951C0B5D5320C23637C279 | preparation-assessments-v3.8.json/195/population_applicability/adult/applicability | Historical; current review incomplete |
H51-D4D3F1BF50484452F8427260 | preparation-assessments-v3.8.json/195/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-19C64DBDF15F8ED112242C31 | preparation-assessments-v3.8.json/195/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-935D95FAAD95CA2493FCD60A | preparation-assessments-v3.8.json/195/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-ADF001A854BFA9F33BC812CB | preparation-assessments-v3.8.json/195/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-08BD2770FBD69D8FD6211226 | preparation-assessments-v3.8.json/195/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-52172503AED240D7AB486A19 | preparation-assessments-v3.8.json/195/route_presence/structured_dilution | Historical; current review incomplete |
H51-417BC17F2CBE554DA41B1FEA | preparation-assessments-v3.8.json/195/route_presence/iv_push | Historical; current review incomplete |
H51-ECEEF6F4739F612A9C5993B4 | preparation-assessments-v3.8.json/195/route_presence/continuous_infusion | Historical; current review incomplete |
H51-812CF83223FC0A191B997C2E | preparation-assessments-v3.8.json/195/route_presence/pediatric_source | Historical; current review incomplete |
H51-169C445EC0325E8DD05B558C | preparation-assessments-v3.8.json/195/route_presence/neonatal_source | Historical; current review incomplete |
H51-5F7B29BC94F2C69CB4EA9DC6 | preparation-assessments-v3.8.json/195/legacy_reference/status | Historical; current review incomplete |
H51-78545FD5B529737AE510BC7D | preparation-assessments-v3.8.json/195/label_resolution/status | Historical; current review incomplete |
H51-4887DFF354A015592D34598C | preparation-assessments-v3.8.json/195/source_files/0 | Historical; current review incomplete |
H51-6C983FC7DE178DF879F2C4F6 | preparation-assessments-v3.8.json/195/source_files/1 | Historical; current review incomplete |
H51-580E0FF5C7DFF5AFA8A77F61 | preparation-assessments-v3.8.json/195/source_files/2 | Historical; current review incomplete |
H51-E4BCE1448A812010AC76DAA6 | preparation-assessments-v3.8.json/195/source_files/3 | Historical; current review incomplete |
H51-C2795F4717CE969B52568C7D | preparation-assessments-v3.8.json/195/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)